論文

査読有り 国際誌
2022年9月

Impact of COVID‐19 pandemic on epilepsy care in Japan: A national‐level multicenter retrospective cohort study

Epilepsia Open
  • Naoto Kuroda
  • Takafumi Kubota
  • Toru Horinouchi
  • Naoki Ikegaya
  • Yu Kitazawa
  • Satoshi Kodama
  • Izumi Kuramochi
  • Teppei Matsubara
  • Naoto Nagino
  • Shuichiro Neshige
  • Temma Soga
  • Yutaro Takayama
  • Daichi Sone
  • 全て表示

7
3
開始ページ
431
終了ページ
441
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1002/epi4.12616
出版者・発行元
Wiley

OBJECTIVE: The impact of the coronavirus disease 2019 (COVID-19) pandemic on epilepsy care across Japan was investigated by conducting a multicenter retrospective cohort study. METHODS: This study included monthly data on the frequency of (1) visits by outpatients with epilepsy, (2) outpatient electroencephalography (EEG) studies, (3) telemedicine for epilepsy, (4) admissions for epilepsy, (5) EEG monitoring, and (6) epilepsy surgery in epilepsy centers and clinics across Japan between January 2019 and December 2020. We defined the primary outcome as epilepsy-center-specific monthly data divided by the 12-month average in 2019 for each facility. We determined whether the COVID-19 pandemic-related factors (such as year [2019 or 2020], COVID-19 cases in each prefecture in the previous month, and the state of emergency) were independently associated with these outcomes. RESULTS: In 2020, the frequency of outpatient EEG studies (-10.7%, p<0.001) and cases with telemedicine (+2,608%, p=0.031) were affected. The number of COVID-19 cases was an independent associated factor for epilepsy admission (-3.75*10-3 % per case, p<0.001) and EEG monitoring (-3.81*10-3 % per case, p = 0.004). Further, the state of emergency was an independent factor associated with outpatient with epilepsy (-11.9%, p<0.001), outpatient EEG (-32.3%, p<0.001), telemedicine for epilepsy (+12,915%, p<0.001), epilepsy admissions (-35.3%; p<0.001), EEG monitoring (-24.7%: p<0.001), and epilepsy surgery (-50.3%, p<0.001). SIGNIFICANCE: We demonstrated the significant impact that the COVID-19 pandemic had on epilepsy care. These results support those of previous studies and clarify the effect size of each pandemic-related factor on epilepsy care.

リンク情報
DOI
https://doi.org/10.1002/epi4.12616
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/35633311
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348370
URL
https://onlinelibrary.wiley.com/doi/pdf/10.1002/epi4.12616
URL
https://onlinelibrary.wiley.com/doi/full-xml/10.1002/epi4.12616
ID情報
  • DOI : 10.1002/epi4.12616
  • ISSN : 2470-9239
  • eISSN : 2470-9239
  • PubMed ID : 35633311
  • PubMed Central 記事ID : PMC9348370

エクスポート
BibTeX RIS